Tony Pelz was a trader on a major European bank's proprietary trading desk, responsible for a portfolio with limits of more than $200 million. Prior to proprietary trading, Pelz worked with several global investment banks in roles ranging from corporate finance, M&A to credit and business development. He is author of The Biotech Trader Handbook, 2nd Edition, co-founder of the small-cap biotech research and trading site Chimera Research Group and operator of PelzOptions.com. Pelz currently resides in Denver, Colorado where he trades for his own account.
Recent Articles By The Author
How To Trade Peregrine Pharma's Lung Cancer Fiasco
Options expert Tony Pelz outlines a short-biased trade to play Peregrine's decline.
Options 'Flow' Foretold Questcor Plunge
Tony Pelz shows investors how to monitor unusual options trades to manage risk.
Sarepta Therapeutics: A High-Octane Options Trade
Tony Pelz offers an options trading strategy for investing in Sarepta and next month's eteplirsen data presentation.
Trading Biotech With Options: Exelixis
Tony Pelz debuts a new column focused on using options to invest and trade in biotech stocks.